drug
WVE-007
Phase 2updated 5mo agoby $WVE Wave Life Sciences Ltd.
Phase 2community read0 votes
indications
indications
Obesity
all catalysts(0)
nothing on the calendar yet
Trials studying WVE-007
News(1)
- Moonwalk reloads with $70M and new RNAi prospects for obesityThe California biotech plans to bring its first drug, enabled by licensing technology from a Chinese drugmaker, into clinical testing for obesity by the end of 2027.biopharma_dive · 25d ago
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that